Browse our press packs

Researchers have shown that a fatty acid binding protein is a key target linked to more aggressive disease and poorer survival in multiple myeloma.

Researchers have built a model to predict how local tailoring of pandemic control measures such as lockdowns can halt disease transmission while reducing societal burden.

A subset of individuals with SARS-CoV-2 are three times more likely to spread the virus to other individuals than the average person.

A decade-long analysis reveals potential bottlenecks in the pathway of clinical research into medical practice.

PLATCOV, a platform to assess the effectiveness of drugs against COVID-19, suggests that ivermectin has no significant antiviral activity against SARS-CoV-2.

Just one or two mutations with strong effects, or an accumulation of mutations with small effects, may help the Omicron variant of SARS-CoV-2 dodge the immune system or antibody-based therapies.

The expanded service will provide biophysicists with a new way of validating their research.

High-profile news coverage that eLife papers generated in January 2023, including The Washington Post, The New York Times and Earth.com.

When deciding on responses to a new stimulus, slower initial response times can maximise long-term reward through learning.

An analysis of cancer diagnosis and treatment highlights inconsistencies in the way lag times are calculated and suggests more standardised approaches are needed.